Stevia Safety: Is It Really the Healthiest Sweetener?

What is stevia?

Stevia is a genus of plants in the sunflower family (Asteraceae), native to South America. The species used commercially is Stevia rebaudiana, cultivated primarily in Paraguay, China, and Kenya. The leaves of the plant contain a family of compounds called steviol glycosides, which are responsible for its intense sweetness — up to 350 times that of sucrose, depending on the specific glycoside.

There are more than 40 steviol glycosides identified in the plant. Commercial extracts are standardized to a minimum of 95 percent total steviol glycosides and are dominated by rebaudioside A (Reb A) in most products. The glycoside composition matters: different glycosides have different taste profiles, different sweetness intensities, and have been reviewed individually by regulatory bodies.

Steviol glycosides are not absorbed intact in the small intestine. Gut bacteria in the colon cleave the glycoside to release steviol, which is then absorbed, conjugated in the liver, and excreted in urine. This metabolic pathway was central to the original safety assessments by EFSA and JECFA (the joint FAO/WHO expert committee on food additives).

FDA and EFSA regulatory status

The FDA's GRAS determination for stevia is specific and limited. GRN 252 (2008), submitted by Cargill and covering rebaudioside A at 97%+ purity, was the first notification accepted. It does not cover whole-leaf stevia, crude stevia extracts, or stevia blends where the glycoside fraction is below 95 percent purity. The FDA has since accepted additional GRAS notifications covering other high-purity steviol glycosides including Reb M and Reb D (GRN 737, 2017).

EFSA completed its evaluation of steviol glycosides in 2010, establishing an ADI of 4 mg per kilogram of body weight per day, expressed as steviol equivalents. This ADI was based on a 100-fold safety factor applied to the no-observed-adverse-effect level (NOAEL) from rat studies. JECFA had established the same ADI in 2008.

For a 70 kg adult, the ADI corresponds to 280 mg of steviol per day, or roughly 700–980 mg of high-purity steviol glycosides. This is equivalent to approximately 9–14 packets of a standard tabletop stevia product per day — a level that represents high-end consumption for most users.

Steviol glycosides: not all stevia is the same

One of the most practically relevant aspects of stevia safety evaluation is that "stevia" in a product label tells you very little about the actual compound present. The glycoside fraction, purity level, and processing method all vary significantly between products.

The taste differences between glycosides are meaningful for product development. Reb M and Reb D — present in very small amounts in the raw plant but producible at scale via fermentation — have significantly cleaner taste profiles than Reb A. Several large food manufacturers reformulated products between 2022 and 2025 to use Reb M in place of Reb A specifically to reduce the bitter aftertaste that has limited stevia adoption.

What the research shows: gut microbiota and other findings

The primary area of emerging research concern for stevia is its potential effect on gut microbiota. A 2019 study published in Nutrients (Ruiz-Ojeda et al.) reviewed evidence suggesting that high concentrations of steviol glycosides may inhibit the growth of certain beneficial gut bacteria, including Lactobacillus reuteri, in vitro. The concentrations used in those experiments were substantially higher than typical dietary exposure.

A 2021 study in PNAS (Bian et al.) found that stevia consumption altered the gut microbiome composition in mice at doses higher than typical human intake, and observed downstream effects on immune signaling. These findings have not been replicated in human clinical trials at dietary exposure levels. The research is ongoing and does not constitute evidence of harm at current consumer use levels, but it is an active area of investigation.

On the other side of the evidence ledger: multiple randomized controlled trials have found no significant effect of high-purity steviol glycosides on blood glucose, insulin response, body weight, or blood pressure in both healthy adults and people with type 2 diabetes. A 2020 meta-analysis in Obesity Reviews (McGill et al.) found no statistically significant effect on fasting blood glucose or insulin across 15 trials.

Stevia vs. aspartame and other sweeteners

Stevia is frequently positioned against aspartame in consumer conversations about sweetener safety. The regulatory comparison is straightforward: both are approved, both carry ADIs, both have extensive safety databases. Aspartame has a larger volume of human safety data spanning over 40 years and was reclassified by IARC as "possibly carcinogenic" (Group 2B) in 2023 — a classification reflecting limited evidence rather than established harm, and one that prompted no change in ADI from EFSA or the FDA.

Stevia does not carry an IARC carcinogenicity classification. The available genotoxicity and carcinogenicity data for steviol glycosides are negative. This is a meaningful difference in the evidence record, though it partly reflects the shorter history of stevia as an approved additive.

For detailed profiles of other sweeteners, see our guides on aspartame, sucralose, and monk fruit extract, or browse the full sweetener additives category.

What is actually in Truvia, Stevia in the Raw, and other branded products

Most consumer-facing "stevia" products are blends where stevia-derived compounds represent a minority of the total content by weight. Understanding the blend matters because some reported effects — bloating, digestive discomfort — are more accurately attributed to the bulking agents than to the steviol glycosides themselves.

Truvia (Cargill/Coca-Cola): the primary ingredient is erythritol, a sugar alcohol. Stevia leaf extract (Reb A) is listed third, after natural flavors in some formulations. Erythritol is generally well-tolerated but can cause gastrointestinal effects at high intake levels. Truvia's safety profile is therefore partly determined by the erythritol content.

Stevia in the Raw (Cumberland Packing): the primary ingredient is maltodextrin, a processed starch derived from corn. Maltodextrin has a glycemic index of approximately 85–105 — higher than table sugar. A single packet contains a small enough amount that the glycemic impact is negligible, but consumers using stevia specifically to avoid blood sugar effects should be aware of this formulation choice.

Frequently asked questions about stevia